Cargando…
EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
The aim of this study was to evaluate the prognostic impact of prostaglandin E2 receptor 3 (EP3) receptor expression might have on the two different breast cancer entities: multifocal/multicentric versus unifocal. As the prognosis determining aspects, we investigated the overall- and disease-free su...
Autores principales: | Zati Zehni, Alaleh, Jeschke, Udo, Hester, Anna, Kolben, Thomas, Ditsch, Nina, Jacob, Sven-Niclas, Mumm, Jan-Niclas, Heidegger, Helene Hildegard, Mahner, Sven, Vilsmaier, Theresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352354/ https://www.ncbi.nlm.nih.gov/pubmed/32580276 http://dx.doi.org/10.3390/ijms21124418 |
Ejemplares similares
-
Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality
por: Zati zehni, Alaleh, et al.
Publicado: (2019) -
The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer
por: Zehni, Alaleh Zati, et al.
Publicado: (2021) -
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
por: Vilsmaier, Theresa, et al.
Publicado: (2020) -
Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer
por: Zati zehni, Alaleh, et al.
Publicado: (2021) -
The role of EP-2 receptor expression in cervical intraepithelial neoplasia
por: Schmoeckel, Elisa, et al.
Publicado: (2020)